A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/20 (2006.01) A61K 38/13 (2006.01)
Patent
CA 2228379
A combination of interleukin-10 and cyclosporin is used to suppress graft- versus-host disease, autoimmune diseases and tissue/graft rejection. It has been discovered that administration of a combination of interleukin-10 and cyclosporin causes synergistic suppression of T cell proliferation. Concurrent use of both agents avoids the toxicity associated with higher doses of cyclosporin.
L'invention concerne une combinaison d'interleukine-10 et de cyclosporine pour éviter la réaction de la greffe contre l'hôte, le rejet de la greffe par l'hôte et comme traitement contre les maladies auto-immunes. On a découvert que l'administration d'une combinaison d'interleukine-10 et de cyclosporine a un effet synergique d'inhibition de la prolifération des leucocytes T. L'utilisation simultanée de ces deux agents évite les problèmes de toxicité associés avec des doses plus élevées de cyclosporine.
Ogilvy Renault
Schering Corporation
LandOfFree
Combined use of interleukin-10 and cyclosporin for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combined use of interleukin-10 and cyclosporin for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined use of interleukin-10 and cyclosporin for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2069247